en
de
Contact
COMPANY
PORTFOLIO
INVESTORS
Search
Share Price
Net Asset Value (NAV)
Financial Reports
Press Releases
Presentations
Investment Guidelines
Significant Shareholders
Management Transactions
Calendar
FAQ
News Service
HBM BioVentures registered share
News
HBM BioVentures publishes annual results for 2011/12
Enanta signs significant collaboration agreement with Novartis for Hepatitis C programme
more
Financial Reports
Quarterly Report December 2011
more
Company Presentation
more
Share Price
SIX Swiss Exchange Ticker
HBMN
Key Figures
as at 15 May 2012
CHF
NAV per share
58.98
Net assets
533 Mio.
© HBM BioVentures Ltd
Credits
Important legal information